Raúl Álvaro

558 total citations
19 papers, 404 citations indexed

About

Raúl Álvaro is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Raúl Álvaro has authored 19 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Raúl Álvaro's work include Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Pesticide Residue Analysis and Safety (3 papers). Raúl Álvaro is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Pesticide Residue Analysis and Safety (3 papers). Raúl Álvaro collaborates with scholars based in United States. Raúl Álvaro's co-authors include Peter G. Wislocki, Anthony Y.H. Lu, Frank J. Wolf, Gloria Y. Kwei, Howard J. Jenkins, Qing‐Hui Chen, Gerald T. Miwa, John R. Strauss, Carol Keohane and Todd R. Pippert and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

Raúl Álvaro

19 papers receiving 389 citations

Peers

Raúl Álvaro
Gordon W. Duncan United States
L. García Mexico
Helgi Jung Mexico
R. F. Palmer United Kingdom
B. Kaye United Kingdom
S. Sved Canada
Gordon W. Duncan United States
Raúl Álvaro
Citations per year, relative to Raúl Álvaro Raúl Álvaro (= 1×) peers Gordon W. Duncan

Countries citing papers authored by Raúl Álvaro

Since Specialization
Citations

This map shows the geographic impact of Raúl Álvaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raúl Álvaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raúl Álvaro more than expected).

Fields of papers citing papers by Raúl Álvaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raúl Álvaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raúl Álvaro. The network helps show where Raúl Álvaro may publish in the future.

Co-authorship network of co-authors of Raúl Álvaro

This figure shows the co-authorship network connecting the top 25 collaborators of Raúl Álvaro. A scholar is included among the top collaborators of Raúl Álvaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raúl Álvaro. Raúl Álvaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Dropinski, James F., Yong Zhang, Conrad Santini, et al.. (2005). Novel 2,3-Dihydrobenzofuran-2-carboxylic Acids:  Highly Potent and Subtype-Selective PPARα Agonists with Potent Hypolipidemic Activity. Journal of Medicinal Chemistry. 48(17). 5589–5599. 87 indexed citations
2.
Romanyshyn, Leslie, Philip R. Tiller, Raúl Álvaro, António Sousa Pereira, & Cornelis E. C. A. Hop. (2001). Ultra‐fast gradient vs. fast isocratic chromatography in bioanalytical quantification by liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 15(5). 313–319. 37 indexed citations
3.
Kwei, Gloria Y., Raúl Álvaro, Qing‐Hui Chen, et al.. (1999). Disposition of Ivermectin and Cyclosporin A in CF-1 Mice Deficient in mdr1a P-Glycoprotein. Drug Metabolism and Disposition. 27(5). 581–587. 100 indexed citations
4.
Thompson, Kathryn, S H Vincent, Randall R. Miller, et al.. (1997). Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.. PubMed. 25(10). 1113–8. 37 indexed citations
5.
Thompson, Andrew S., Stella Vincent, Raúl Álvaro, et al.. (1995). The Role of Drug Metabolism in Drug Discovery: A Case Study in the Selection of an Oxytocin Receptor Antagonist for Development. Toxicologic Pathology. 23(2). 124–130. 12 indexed citations
6.
Álvaro, Raúl, Peter G. Wislocki, Gerald T. Miwa, & Anthony Y.H. Lu. (1992). Drug residue formation from ronidazole, a 5-nitroimidazole. VIII. Identification of the 2-methylene position as a site of protein alkylation. Chemico-Biological Interactions. 82(1). 21–30. 16 indexed citations
7.
Álvaro, Raúl, Avery Rosegay, & Shuet-Hing Lee Chiu. (1992). Determination of enantiomeric concentrations of a 2,5-diaryltetrahydrofuran (L-668,750), a platelet-activating factor receptor antagonist, in rat plasma using a chiral α1-acid glycoprotein high-performance liquid chromatographic column. Journal of Chromatography B Biomedical Sciences and Applications. 578(2). 327–332. 2 indexed citations
8.
Vincent, Styliani H., et al.. (1991). Effects of the immunosuppressant FK-506 and its analog FK-520 on hepatic and renal cytochrome P450 mixed-function oxidase. Biochemical Pharmacology. 41(9). 1325–1330. 6 indexed citations
9.
Maynard, Michael S., et al.. (1990). Fate of avermectin B1a in rats. Journal of Agricultural and Food Chemistry. 38(3). 864–870. 11 indexed citations
10.
Maynard, Michael S., et al.. (1989). Fate of the 8,9-Z isomer of avermectin B1a in rats. Journal of Agricultural and Food Chemistry. 37(6). 1487–1491. 5 indexed citations
11.
Miwa, Gerald T., Regina Wang, Raúl Álvaro, John Walsh, & Anthony Y.H. Lu. (1986). The metabolic activation of ronidazole [(1-methyl-5-nitroimidazole-2-yl)-methyl carbamate] to reactive metabolites by mammalian, cecal bacterial and T. foetus enzymes. Biochemical Pharmacology. 35(1). 33–36. 9 indexed citations
12.
Wolf, Frank J., et al.. (1984). Tissue residue studies with ronidazole. Effect of label site on total radioactivity content of rat tissues. Journal of Agricultural and Food Chemistry. 32(4). 706–711. 2 indexed citations
13.
Miwa, Gerald T., Raúl Álvaro, John Walsh, Regina Wang, & Anthony Y.H. Lu. (1984). Drug residue formation from ronidazole, a 5-nitroimidazole. VII. Comparison of protein-bound products formed in vitro and in vivo. Chemico-Biological Interactions. 50(2). 189–202. 10 indexed citations
14.
Wislocki, Peter G., Edward S. Bagan, W.J.A. Vandenheuvel, et al.. (1984). Drug residue formation from ronidazole, a 5-nitroimidazole. V. Cysteine adducts formed upon reduction of ronidazole by dithionite or rat liver enzymes in the presence of cysteine. Chemico-Biological Interactions. 49(1-2). 13–25. 26 indexed citations
15.
Wolf, Frank J., Raúl Álvaro, James J. Steffens, et al.. (1984). Tissue residues due to ronidazole: bioavailability of residues in swine muscle on ingestion by the rat. Journal of Agricultural and Food Chemistry. 32(4). 711–714. 6 indexed citations
16.
Wolf, Frank J., Raúl Álvaro, Albert Lu, et al.. (1983). Drug residue formation from ronidazole, a 5-nitroimidazole. IV. The role of the microflora. Chemico-Biological Interactions. 45(1). 7–14. 6 indexed citations
17.
Wislocki, Peter G., et al.. (1982). Problems associated with the use of cycloheximide to distinguish between animal drug residues bound to protein and those incorporated into protein. Food and Chemical Toxicology. 20(4). 413–416. 3 indexed citations
18.
Jacob, Theodore A., et al.. (1982). Tissue residues of arprinocid in chickens. 1. Depletion of residues in tissues of chickens fed carbon-14-labeled arprinocid. Journal of Agricultural and Food Chemistry. 30(2). 248–253. 1 indexed citations
19.
West, S.B., et al.. (1982). Drug residue formation from ronidazole, a 5-nitroimidazole. I. Characterization of in vitro protein alkylation. Chemico-Biological Interactions. 41(3). 265–279. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026